Inhibitory effect of enalapril on serum aldosterone in essential hypertension. 1987

R A Sánchez, and A J Ramírez, and M Muscara, and B H Gilbert, and E Marcó, and L I Moledo

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D004656 Enalapril An angiotensin-converting enzyme inhibitor that is used to treat HYPERTENSION and HEART FAILURE. Enalapril Maleate,MK-421,MK421,Renitec,Renitek,MK 421,Maleate, Enalapril
D005260 Female Females
D006339 Heart Rate The number of times the HEART VENTRICLES contract per unit of time, usually per minute. Cardiac Rate,Chronotropism, Cardiac,Heart Rate Control,Heartbeat,Pulse Rate,Cardiac Chronotropy,Cardiac Chronotropism,Cardiac Rates,Chronotropy, Cardiac,Control, Heart Rate,Heart Rates,Heartbeats,Pulse Rates,Rate Control, Heart,Rate, Cardiac,Rate, Heart,Rate, Pulse
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

R A Sánchez, and A J Ramírez, and M Muscara, and B H Gilbert, and E Marcó, and L I Moledo
January 1989, Clinical therapeutics,
R A Sánchez, and A J Ramírez, and M Muscara, and B H Gilbert, and E Marcó, and L I Moledo
February 2023, Journal of clinical hypertension (Greenwich, Conn.),
R A Sánchez, and A J Ramírez, and M Muscara, and B H Gilbert, and E Marcó, and L I Moledo
April 1990, Zhonghua xin xue guan bing za zhi,
R A Sánchez, and A J Ramírez, and M Muscara, and B H Gilbert, and E Marcó, and L I Moledo
January 1985, Drugs,
R A Sánchez, and A J Ramírez, and M Muscara, and B H Gilbert, and E Marcó, and L I Moledo
April 1988, Zhonghua xin xue guan bing za zhi,
R A Sánchez, and A J Ramírez, and M Muscara, and B H Gilbert, and E Marcó, and L I Moledo
February 1992, The Journal of the Association of Physicians of India,
R A Sánchez, and A J Ramírez, and M Muscara, and B H Gilbert, and E Marcó, and L I Moledo
June 1989, Revista medica de Chile,
R A Sánchez, and A J Ramírez, and M Muscara, and B H Gilbert, and E Marcó, and L I Moledo
August 2010, Journal of Zhejiang University. Science. B,
R A Sánchez, and A J Ramírez, and M Muscara, and B H Gilbert, and E Marcó, and L I Moledo
May 1989, The American journal of cardiology,
R A Sánchez, and A J Ramírez, and M Muscara, and B H Gilbert, and E Marcó, and L I Moledo
January 1993, Clinical therapeutics,
Copied contents to your clipboard!